1N1 Stock Overview Develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Nanalysis Scientific Corp. Competitors Price History & Performance
Summary of share price highs, lows and changes for Nanalysis Scientific Historical stock prices Current Share Price CA$0.20 52 Week High CA$0.43 52 Week Low CA$0.17 Beta 0.64 1 Month Change -2.86% 3 Month Change -7.27% 1 Year Change -41.71% 3 Year Change -74.66% 5 Year Change -51.43% Change since IPO -27.92%
Recent News & Updates
Nanalysis Scientific Corp. to Report Q3, 2024 Results on Nov 21, 2024 Nov 07
Second quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.039 loss in 2Q 2023) Aug 29
Nanalysis Scientific Corp. to Report Q2, 2024 Results on Aug 28, 2024 Aug 14
High number of new and inexperienced directors Jul 02
First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.042 loss in 1Q 2023) Jun 02
Nanalysis Scientific Corp. to Report Q1, 2024 Results on May 29, 2024 May 23 See more updates
Nanalysis Scientific Corp. to Report Q3, 2024 Results on Nov 21, 2024 Nov 07
Second quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.039 loss in 2Q 2023) Aug 29
Nanalysis Scientific Corp. to Report Q2, 2024 Results on Aug 28, 2024 Aug 14
High number of new and inexperienced directors Jul 02
First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.042 loss in 1Q 2023) Jun 02
Nanalysis Scientific Corp. to Report Q1, 2024 Results on May 29, 2024 May 23
Full year 2023 earnings released: CA$0.16 loss per share (vs CA$0.098 loss in FY 2022) May 01
Nanalysis Scientific Corp., Annual General Meeting, Jun 26, 2024 Apr 28
Nanalysis Scientific Corp. to Report Q4, 2023 Results on Apr 25, 2024 Apr 12
Nanalysis Scientific Corp. Announces Resignation of Kham Lin as A Director Apr 10 Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances Apr 05
Nanalysis Scientific Corp. has completed a Composite Units Offering in the amount of CAD 5 million. Nanalysis Scientific Corp. announced that it expects to receive CAD 1 million in funding Mar 07
Nanalysis Scientific Corp. Provides Earnings Guidance for the Fourth Quarter 2023 Feb 07
New major risk - Share price stability Jan 18
Third quarter 2023 earnings released: CA$0.06 loss per share (vs CA$0.026 loss in 3Q 2022) Dec 01
Nanalysis Scientific Corp. to Report Q3, 2023 Results on Nov 29, 2023 Nov 17
Second quarter 2023 earnings released: CA$0.04 loss per share (vs CA$0.024 loss in 2Q 2022) Aug 25
Nanalysis Scientific Corp. to Report Q2, 2023 Results on Aug 24, 2023 Aug 16
Nanalysis Scientific Corp. to Report Q1, 2023 Results on May 25, 2023 May 19 Nanalysis Scientific Corp. announced that it has received CAD 4.1287 million in funding May 04
Full year 2022 earnings released: CA$0.10 loss per share (vs CA$0.025 loss in FY 2021) Apr 30
Third quarter 2022 earnings released: CA$0.026 loss per share (vs CA$0.012 loss in 3Q 2021) Dec 01
High number of new and inexperienced directors Nov 16
Nanalysis Scientific Corp. to Report Q3, 2022 Results on Nov 29, 2022 Nov 16
Nanalysis Scientific Corp. Provides Revenue Guidance for the Third Quarter Ended September 30, 2022 Oct 21
Second quarter 2022 earnings released: CA$0.02 loss per share (vs CA$0.003 profit in 2Q 2021) Aug 26
Nanalysis Scientific Corp. to Report Q2, 2022 Results on Aug 25, 2022 Aug 11
Nanalysis Scientific Corp. Announces Executive Changes Jul 22
Nanalysis Scientific Corp. Announces Appointment of Kham Lin as New Director Jun 24
First quarter 2022 earnings released: CA$0.02 loss per share (vs CA$0.007 loss in 1Q 2021) Jun 01
Nanalysis Scientific Corp. to Report Q1, 2022 Results on May 31, 2022 May 25
Full year 2021 earnings released: CA$0.03 loss per share (vs CA$0.056 loss in FY 2020) Apr 30
High number of new and inexperienced directors Apr 27
Nanalysis Scientific Corp. to Report Fiscal Year 2021 Results on Apr 28, 2022 Apr 21 Nanalysis Scientific Corp. has completed a Follow-on Equity Offering in the amount of CAD 10.725 million. Feb 12
Nanalysis Scientific Corp. (TSXV:NSCI) completed the acquisition of K'(Prime) Technologies Inc. Jan 13
Nanalysis Scientific Corp. announced that it expects to receive CAD 0.2025 million in funding Dec 17
High number of new and inexperienced directors Dec 06
Third quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.017 loss in 3Q 2020) Nov 19
Nanalysis Scientific Corp. has completed a Composite Units Offering in the amount of CAD 8.00004 million. Aug 27
Second quarter 2021 earnings released Aug 27
Nanalysis Scientific Corp. announced that it has received CAD 1.797638 million in funding Aug 26
First quarter 2021 earnings released: CA$0.007 loss per share (vs CA$0.014 loss in 1Q 2020) May 21
Full year 2020 earnings released: CA$0.056 loss per share (vs CA$0.03 loss in FY 2019) Apr 24
Nanalysis Scientific Corp. Signs Strategic OEM Partnership for Magnetic Resonance Electronics Sales Jan 14
New 90-day high: €0.35 Jan 08
Third quarter 2020 earnings released: CA$0.017 loss per share Nov 28
New 90-day low: €0.24 Oct 08
New 90-day low - €0.27 Sep 15
First half earnings released Aug 23 Shareholder Returns 1N1 DE Medical Equipment DE Market 7D -6.4% 2.9% 1.9% 1Y -41.7% -1.0% 15.1%
See full shareholder returns
Return vs Market: 1N1 underperformed the German Market which returned 15.2% over the past year.
Price Volatility Is 1N1's price volatile compared to industry and market? 1N1 volatility 1N1 Average Weekly Movement 10.1% Medical Equipment Industry Average Movement 6.2% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.2% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 1N1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 1N1's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60 MHz and 100 MHz NMR platform; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching.
Show more Nanalysis Scientific Corp. Fundamentals Summary How do Nanalysis Scientific's earnings and revenue compare to its market cap? 1N1 fundamental statistics Market cap €23.27m Earnings (TTM ) -€5.50m Revenue (TTM ) €28.54m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 1N1 income statement (TTM ) Revenue CA$43.01m Cost of Revenue CA$32.73m Gross Profit CA$10.28m Other Expenses CA$18.56m Earnings -CA$8.28m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.073 Gross Margin 23.90% Net Profit Margin -19.26% Debt/Equity Ratio 67.7%
How did 1N1 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/31 09:47 End of Day Share Price 2025/01/31 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Nanalysis Scientific Corp. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Douglas Loe Leede Financial Inc Stefan Quenneville Ventum Financial Corp
Show 0 more analysts 
